SUMMIT MEDICAL LTD CELLTRANS POSTOPERATIVE AUTOTRANSFUSION SYSTEM, MODELS ABT4510, ABT4512 & ABT4514

Apparatus, Autotransfusion

SUMMIT MEDICAL LTD.

The following data is part of a premarket notification filed by Summit Medical Ltd. with the FDA for Summit Medical Ltd Celltrans Postoperative Autotransfusion System, Models Abt4510, Abt4512 & Abt4514.

Pre-market Notification Details

Device IDK022489
510k NumberK022489
Device Name:SUMMIT MEDICAL LTD CELLTRANS POSTOPERATIVE AUTOTRANSFUSION SYSTEM, MODELS ABT4510, ABT4512 & ABT4514
ClassificationApparatus, Autotransfusion
Applicant SUMMIT MEDICAL LTD. BUSINESS & TECHNOLOGY CENTRE BESSEMER DRIVE Stevenage Hertfordshire,  GB Sgi 2dx
ContactNeil R Armstrong
CorrespondentNeil R Armstrong
SUMMIT MEDICAL LTD. BUSINESS & TECHNOLOGY CENTRE BESSEMER DRIVE Stevenage Hertfordshire,  GB Sgi 2dx
Product CodeCAC  
CFR Regulation Number868.5830 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-07-29
Decision Date2002-10-09
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
25060238201135 K022489 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.